Lange, TS and McCourt, C and Singh, RK and Kyu, KK and Singh, AP and Luisi, BS and Alptürk, O and Strongin, RM and Brard, L
(2009)
Apoptotic and chemotherapeutic properties of iron(III)-salophene in an ovarian cancer animal model.
Drug Design, Development and Therapy (3).
17 - 26.
Abstract
The cytotoxicity of organometallic compounds iron(III)-, cobalt(III)-, manganese(II)-, and copper(II)-salophene (-SP) on platinum-resistant ovarian cancer cell lines was compared. Fe-SP displayed selective cytotoxicity (IC 50 at ∼1 μM) against SKOV-3 and OVCAR-3 cell lines while Co-SP caused cytotoxic effects only at higher concentrations (IC50 at 60 ?M) and Cu-SP effects were negligible. High cytotoxicity of Mn-SP (30-60 μM) appeared to be nonspecific because the Mn-chloride salt reduced cell viability similarly. The effect of Fe-SP at 1 μM proved to be ovarian cancer cell selective when compared to a panel of cell lines derived from different tumors. The first irreversible step in the induction of cell death by Fe-SP occurred after 3 hrs as indicated by the mitochondrial transmembrane potential (ΔΨm) and was mainly linked to apoptotic, not necrotic events. To evaluate the toxicity of Fe-SP in vivo we conducted an acute toxicity study in rats. The LD 50 of Fe-SP is >2000 mg/kg orally and >5.5 mg/kg body weight by intraperitoneal injection. An ovarian cancer animal model showed that the chemotherapeutic relevant dose of Fe-SP in rats is 0.5-1 mg/kg body weight. The present report suggests that Fe-SP is a potential therapeutic drug to treat ovarian cancer. © 2009 Lange et al, publisher and licensee Dove Medical Press Ltd.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID |
---|
Lange, TS | | | | McCourt, C | | | | Singh, RK | | | | Kyu, KK | | | | Singh, AP | | | | Luisi, BS | | | | Alptürk, O | | | | Strongin, RM | | | | Brard, L | | | |
|
Date: |
1 October 2009 |
Date Type: |
Publication |
Journal or Publication Title: |
Drug Design, Development and Therapy |
Number: |
3 |
Page Range: |
17 - 26 |
Schools and Programs: |
School of Medicine > Medicine |
Refereed: |
Yes |
Date Deposited: |
17 Dec 2012 18:53 |
Last Modified: |
19 Jun 2021 10:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/16894 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
|
View Item |